secwatch.observer — SEC 8-K summary
======================================

Issuer:     IGC Pharma, Inc. (IGC)
CIK:        0001326205
Form:       8-K
Filed at:   2025-11-14T23:59:59+00:00
Accession:  0001185185-25-001713
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IGC Pharma closes sale of Vancouver facility assets for ~$2.7M in non-cash consideration
--------------------------------------------------------------------------------

- Closed Nov 13, 2025; subsidiary Holi Hemp sold equipment, inventory, and leasehold assets to Wellness Essentials Northwest LLC.
- Total fair value of consideration ~$2.7M, comprising preferential manufacturing rights through Dec 2030 and 10% contingent payment if buyer sells within 5 years.
- Pro forma gain on disposal of $1.05M recognized; intangible asset of $2.7M recorded for supply contract.
- No cash received; deal secures manufacturing capacity at preferential pricing starting 2028.
- Pro forma balance sheet shows total assets of $8.99M and stockholders' equity of $7.13M as of June 30, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326205/000118518525001713/0001185185-25-001713-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326205/000118518525001713/igc8k111425.htm
  HTML page:      https://secwatch.observer/filing/0001185185-25-001713

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer